The asset was acquired for a development completion price of $446.2 million , making the transaction one of the largest single-asset private healthcare acquisitions in Australia.

The Australian Bragg Centre building (also known as SAHMRI 2) is a state-of-the-art clinical and research facility within Adelaide’s $3.6 billion BioMed City precinct, incorporating world-class facilities for cutting edge research by the South Australian Health and Medical Research Institute (SAHMRI) and lab and office space for SA Health and biomedical companies. The building will house Australia’s first proton therapy unit specialising in next generation cancer treatment. The proton therapy unit will sit in a purpose-built bunker and be overseen by the clinical and research expertise of SAHMRI and is supported by Federal and State Government funding.

The building, which is currently under development, is 77% pre-leased to customers either backed or supported by the South Australian Government, with a weighted average lease expiry2 of 21.9 years from completion in August 2023. The acquisition terms include a two-year rental guarantee provided by Commercial & General over the remaining space to be leased.

On completion, the Australian Bragg Centre will increase Dexus’s group healthcare exposure to over $1 billion and grow HWPF’s portfolio to $900 million.

Dexus CEO, Darren Steinberg said: “This transaction accelerates the growth of our funds management platform and is a step towards our goal of being a partner of choice in Australian healthcare property. It also increases Dexus’s portfolio diversification, providing exposure to a sector with strong tailwinds.”

Dexus Executive General Manager, Funds Management, Deborah Coakley said: “This is an exciting milestone for HWPF that secures a landmark, large-scale healthcare asset, diversifying the fund’s portfolio of high-quality healthcare properties.”

Commercial & General CEO, Trevor Cooke said: “This is a vote of confidence by the institutional market in the South Australian economy and the quality opportunities we continue to create. The Australian Bragg Centre is a transformational project that builds on our long-standing relationship with Dexus.”

The transaction is expected to settle on 30 October 2020.

Authorised by Brett Cameron, General Counsel and Company Secretary of Dexus Funds Management Limited.

Similar to this: 

Adelaide's NAB House sold to Singaporean family for $47.2 million through Knight Frank

Economic crisis casts a shadow over Australia’s CBD office markets - JLL

Quintessential Equity complete $8 million refurbishment of Adelaide CBD office building